GH Research Announces Pricing of $117.5 Million Underwritten Offering
Summary
DUBLIN, April 29, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of pat...
Description
DUBLIN, April 29, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of pat...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source